Other Updated 2022-04-14

Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant

See all recalls from Sotrovimab →
Share: Facebook X / Twitter WhatsApp

Recalled Product

Sotrovimab, 500 mg IV


✅ What Should You Do?

  1. ⚠️ Stop using this product until you have checked the recall details below.
  2. Follow the instructions from the issuing agency (see below).
  3. 💰 Check if you are eligible for a refund or free replacement from the retailer or manufacturer.
  4. 📋 Report a product safety incident to Health Canada
Looking for a safe alternative? Search Amazon Canada for Sotrovimab, 500 mg IV →

Hazard / Issue

New safety information - COVID

Issued by

Marketed health products

View official government recall